Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r)

Abstract Background One of the recommended protease inhibitor treatments for HIV is Atazanavir boosted with Ritonavir (ATV/r). However, hyperbilirubinemia is a well-recognized adverse effect of this therapy. Methods This retrospective cross-sectional study analyzed 121 clinical records of people liv...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Hameedreza Farrokhi, Elnaz Shahmohamadi, Ava Pashaei, Hamid Emadi Koochak, Sahar Nooralioghli Parikhani, Masoumeh Fathi Amrollah, Pegah Mirzapour, Seyed Ali Dehghan Manshadi, SeyedAhmad SeyedAlinaghi, Daniel Hackett
Format:	Artigo
Język:	Inglês
Wydane:	BMC 2025-11-01
Seria:	BMC Gastroenterology
Hasła przedmiotowe:	Atazanavir Hyperbilirubinemia People living with HIV Antiretroviral therapy
Dostęp online:	https://doi.org/10.1186/s12876-025-04489-4
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!